Age-related axonal swellings precede other neuropathological hallmarks in a knock-in mouse model of Huntington's disease
暂无分享,去创建一个
[1] S. Dunnett,et al. Mouse Models of Huntington's Disease. , 2015, Current topics in behavioral neurosciences.
[2] A. Hannan,et al. Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington’s disease , 2013, Neuroscience.
[3] G. Ellis‐Davies,et al. In vivo characterization of a bigenic fluorescent mouse model of Alzheimer's disease with neurodegeneration. , 2013, The Journal of comparative neurology.
[4] Michael I. Miller,et al. Spatiotemporal mapping of brain atrophy in mouse models of Huntington's disease using longitudinal in vivo magnetic resonance imaging , 2012, NeuroImage.
[5] M. Chesselet,et al. Striatal atrophy and dendritic alterations in a knock-in mouse model of Huntington's disease , 2012, Brain Research Bulletin.
[6] Å. Petersén,et al. Hypothalamic and Limbic System Changes in Huntington's Disease. , 2012, Journal of Huntington's disease.
[7] L. Menalled,et al. Knock-in mouse models of Huntington’s disease , 2005, NeuroRX.
[8] Francisco Clascá,et al. Mapping of fluorescent protein-expressing neurons and axon pathways in adult and developing Thy1-eYFP-H transgenic mice , 2010, Brain Research.
[9] Shihua Li,et al. Huntingtin-associated Protein-1 Interacts with Pro-brain-derived Neurotrophic Factor and Mediates Its Transport and Release* , 2009, The Journal of Biological Chemistry.
[10] Chun-Fang Huang,et al. Pathogenic Huntingtin Inhibits Fast Axonal Transport by Activating JNK3 and Phosphorylating Kinesin , 2009, Nature Neuroscience.
[11] J. Marsh,et al. Live axonal transport disruption by mutant huntingtin fragments in Drosophila motor neuron axons , 2009, Neurobiology of Disease.
[12] Kurt E. Weaver,et al. Longitudinal diffusion tensor imaging in Huntington's Disease , 2009, Experimental Neurology.
[13] A. Nógrádi,et al. Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies. , 2009, Brain : a journal of neurology.
[14] R. Ribchester,et al. Late onset distal axonal swelling in YFP-H transgenic mice , 2009, Neurobiology of Aging.
[15] A. J. Morton,et al. Use of magnetic resonance imaging for anatomical phenotyping of the R6/2 mouse model of Huntington's disease , 2009, Neurobiology of Disease.
[16] M. Chesselet,et al. Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice , 2008, Neuroscience.
[17] He Li,et al. N-Terminal Mutant Huntingtin Associates with Mitochondria and Impairs Mitochondrial Trafficking , 2008, The Journal of Neuroscience.
[18] A. Giralt,et al. Disruption of striatal glutamatergic transmission induced by mutant huntingtin involves remodeling of both postsynaptic density and NMDA receptor signaling , 2008, Neurobiology of Disease.
[19] J. Glass,et al. NAD+ and axon degeneration revisited: Nmnat1 cannot substitute for WldS to delay Wallerian degeneration , 2007, Cell Death and Differentiation.
[20] G. Pigino,et al. JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport , 2006, Nature Neuroscience.
[21] Sarah A. J. Reading,et al. Regional white matter change in pre-symptomatic Huntington's disease: A diffusion tensor imaging study , 2005, Psychiatry Research: Neuroimaging.
[22] Steven M Hersch,et al. Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice , 2005, The Journal of comparative neurology.
[23] P. Brundin,et al. Synaptic dysfunction in Huntington’s disease: a new perspective , 2005, Cellular and Molecular Life Sciences CMLS.
[24] M. Hayden,et al. Cognitive Dysfunction Precedes Neuropathology and Motor Abnormalities in the YAC128 Mouse Model of Huntington's Disease , 2005, The Journal of Neuroscience.
[25] Mark R. Segal,et al. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death , 2004, Nature.
[26] Jaime Grutzendler,et al. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches , 2004, Nature Neuroscience.
[27] Shihua Li,et al. Huntington and its Role in Neuronal Degeneration , 2004, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[28] E. Seeberg,et al. Mutant Huntingtin Impairs Axonal Trafficking in Mammalian Neurons In Vivo and In Vitro , 2004, Molecular and Cellular Biology.
[29] Fabrice P Cordelières,et al. Huntingtin Controls Neurotrophic Support and Survival of Neurons by Enhancing BDNF Vesicular Transport along Microtubules , 2004, Cell.
[30] J. Littleton,et al. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[31] M. Chesselet,et al. Time course of early motor and neuropathological anomalies in a knock‐in mouse model of Huntington's disease with 140 CAG repeats , 2003, The Journal of comparative neurology.
[32] Richard G. Brusch,et al. Disruption of Axonal Transport by Loss of Huntingtin or Expression of Pathogenic PolyQ Proteins in Drosophila , 2003, Neuron.
[33] He Li,et al. Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release. , 2003, Human molecular genetics.
[34] Carlos Cepeda,et al. Transient and Progressive Electrophysiological Alterations in the Corticostriatal Pathway in a Mouse Model of Huntington's Disease , 2003, The Journal of Neuroscience.
[35] M. Chesselet,et al. Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. , 2001, Journal of neurophysiology.
[36] H Li,et al. Huntingtin Aggregate-Associated Axonal Degeneration is an Early Pathological Event in Huntington's Disease Mice , 2001, The Journal of Neuroscience.
[37] R. Wetzel,et al. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. , 2001, Journal of molecular biology.
[38] G. Feng,et al. Imaging Neuronal Subsets in Transgenic Mice Expressing Multiple Spectral Variants of GFP , 2000, Neuron.
[39] S B Dunnett,et al. Abnormal Synaptic Plasticity and Impaired Spatial Cognition in Mice Transgenic for Exon 1 of the Human Huntington's Disease Mutation , 2000, The Journal of Neuroscience.
[40] J Q Trojanowski,et al. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[41] R. Myers,et al. Impaired synaptic plasticity in mice carrying the Huntington's disease mutation. , 1999, Human molecular genetics.
[42] Claire-Anne Gutekunst,et al. Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology , 1999, The Journal of Neuroscience.
[43] J. Penney,et al. Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease. , 1999, Journal of neuropathology and experimental neurology.
[44] G. M. Halliday,et al. Regional Specificity of Brain Atrophy in Huntington's Disease , 1998, Experimental Neurology.
[45] Steven Finkbeiner,et al. Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.
[46] S. W. Davies,et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. , 1997, Science.
[47] Mark Turmaine,et al. Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.
[48] V. Perry,et al. Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.
[49] S. W. Davies,et al. Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.
[50] T. Robbins,et al. Executive and mnemonic functions in early Huntington's disease. , 1996, Brain : a journal of neurology.
[51] E. Siemers,et al. Cognitive scores in carriers of huntington's disease gene compared to noncarriers , 1995, Annals of neurology.
[52] C. Marsden,et al. Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[53] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[54] J. Penney,et al. Preferential loss of striato‐external pallidal projection neurons in presymptomatic Huntington's disease , 1992, Annals of neurology.
[55] N. Kowall,et al. Neurofilament and neural cell adhesion molecule immunocytochemistry of Huntington's disease striatum , 1992, Annals of neurology.
[56] N W Kowall,et al. Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[57] E. Mohr,et al. Visuospatial cognition in Huntington's disease , 1991, Movement disorders : official journal of the Movement Disorder Society.
[58] J. Penney,et al. Differential loss of striatal projection neurons in Huntington disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[59] J. B. Martin,et al. Selective sparing of a class of striatal neurons in Huntington's disease. , 1985, Science.
[60] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.
[61] G. Graveland,et al. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. , 1985, Science.
[62] F. A. Putt,et al. Histopathologic Technic and Practical Histochemistry , 1954, The Yale Journal of Biology and Medicine.